Model Medicines

Model Medicines, with its CHEMprint™ AI drug discovery platform, leverages the predictive power of artificial intelligence and machine learning to identify drugs that can be repurposed as therapies for patients suffering from some of humanity's most severe diseases. Drugs discovered by Model Medicines can enter clinical trials within just a few months. The company has developed a robust pipeline of patent-pending therapies targeting oncology, infectious diseases, gastrointestinal disorders, neurological conditions, and weight-related illnesses.